help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 3, 2006
Endocrinology, doi:10.1210/en.2006-0707
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/11/5087    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chesterfield, M.
Right arrow Articles by Callahan, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chesterfield, M.
Right arrow Articles by Callahan, P.

Submitted on May 26, 2006
Accepted on July 24, 2006

Orphanin FQ/Nociceptin (OFQ/N) is a Physiological Regulator of Prolactin Secretion in Female Rats

Matthew Chesterfield, James Janik, Emily Murphree, Courtney Lynn, Erin Schmidt, and Phyllis Callahan*

Center for Neuroscience, Department of Zoology (M.C., J.J., D.L., E.S., P.C.) and Department of Mathematics and Statistics (E.M.), Miami University, Oxford, OH 45056

* To whom correspondence should be addressed. E-mail: Callahp{at}muohio.edu.

Orphanin FQ/Nociceptin (OFQ/N), the most recently identified endogenous opioid peptide, stimulates prolactin secretion in both male and female rats. OFQ/N, however, did not elicit this stimulatory effect through the µ, {delta} or {kappa} opiate receptor subtype. The role OFQ/N plays in prolactin regulation under physiological conditions and its mechanism of action are not known. The purpose of these studies was to determine the physiological significance and pharmacological specificity of the prolactin secretory response to OFQ/N. In addition, the role of the TIDA neurons in mediating this response was examined. ORL-1 receptors were blocked by pretreatment with Comp B, a purported OFQ/N antagonist, or receptor synthesis was disrupted by pretreatment with ORL-1 receptor antisense oligonucleotides. The prolactin secretory response to OFQ/N administration in diestrous females was measured. Furthermore, the suckling-induced prolactin response was also determined following Comp B pretreatment. TIDA neuronal activity was quantified in diestrous females rats to determine if OFQ/N stimulates prolactin release by inhibiting TIDA neurons. OFQ/N significantly inhibited the TIDA neurons by one minute, preceding the prolactin secretory response. Both Comp B and antisense pretreatment blocked the stimulatory effects of OFQ/N on prolactin release and Comp B abolished the suckling-induced prolactin response. These studies indicate that OFQ/N is a potent stimulus for prolactin secretion in female rats and it mediates this effect by rapid and transient inhibition of TIDA neuronal activity. Furthermore, OFQ/N plays a physiologically significant role in the regulation of prolactin secretion during lactation and it mediates its effects via actions at the ORL-1 receptor subtype.


Key words: Tuberoinfundibular dopamine • suckling • lactation




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. D. Foradori, M. Amstalden, L. M. Coolen, S. R. Singh, C. J. McManus, R. J. Handa, R. L. Goodman, and M. N. Lehman
Orphanin FQ: Evidence for a Role in the Control of the Reproductive Neuroendocrine System
Endocrinology, October 1, 2007; 148(10): 4993 - 5001.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society